Xin-You Liu
Overview
Explore the profile of Xin-You Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chou J, Chang T, Liu X, Wu T, Chen Y, Hsu Y, et al.
Sensors (Basel)
. 2022 May;
22(9).
PMID: 35591180
The majority of digital sensors rely on von Neumann architecture microprocessors to process sampled data. When the sampled data require complex computation for 24×7, the processing element will a consume...
2.
Song Y, Liu D, Cheng Y, Liu M, Ye W, Zhang B, et al.
Sci Rep
. 2015 Nov;
5:16125.
PMID: 26530454
In order to overcome drug resistant and enhance antitumor activity of DOX, a new pH-sensitive micelle (DOX/DQA-DOX@DSPE-hyd-PEG-AA) was prepared to simultaneously deliver DOX to nucleus and mitochondria. Drug released from...
3.
Qian Y, Liu X, Pei D, Xu J, Shen H, Chen X, et al.
Asian Pac J Cancer Prev
. 2014 Dec;
15(22):9699-706.
PMID: 25520091
Background: The predictive value of the xeroderma pigmentosum group D (XPD) Lys751Gln polymorphism regarding clinical outcomes of patients with colorectal cancer (CRC) receiving oxaliplatin-based chemotherapy has been evaluated in numerous...
4.
Qian Y, Liu X, Wu Q, Song X, Chen X, Liu Y, et al.
Asian Pac J Cancer Prev
. 2014 Oct;
15(19):8383-90.
PMID: 25339033
Background: Although the predictive value of the excision repair cross-complementing group 1 (ERCC1) C118T polymorphism in clinical outcomes of patients with colorectal cancer (CRC) receiving oxaliplatin-based chemotherapy has been evaluated...
5.
Shi L, Dang X, Liu X, Wei H, Yang M, Zhang Y
Arch Pharm Res
. 2014 Apr;
37(12):1617-23.
PMID: 24691829
Carbamazepine (CBZ), an antiepileptic with narrow therapeutic window, is a substrate of CYP 3A4 which metabolizes CBZ to carbamazepine-10,11-epoxide (CBZE). CBZE is an active and toxicity metabolite, and it is...
6.
Yang M, Zhang Y, Liu X, Zhang T, Liu M
Zhong Yao Cai
. 2012 Jan;
34(8):1288-92.
PMID: 22233047
Objective: To optimize the formulation of Chinese herbs' volatile oil micro emulsion. Methods: Sreened the formulation of blank micro-emulsion and the formulation of micro-emulsion contained volatile oil by means of...
7.
Huan M, Zhou S, Teng Z, Zhang B, Liu X, Wang J, et al.
Bioorg Med Chem Lett
. 2009 Mar;
19(9):2579-84.
PMID: 19329312
The synthetic DOX-LNA conjugate was characterized by proton nuclear magnetic resonance and mass spectrometry. In addition, the purity of the conjugate was analyzed by reverse-phase high-performance liquid chromatography. The cellular...
8.
Yang Z, Zhou S, Yang T, Liu X, Mei Q
Biopharm Drug Dispos
. 2008 Dec;
29(9):485-94.
PMID: 19085951
The prototype 1,4-dihydropyridine (1,4-DHP) nifedipine, indicated for the management of hypertension and angina pectoris, has disadvantages including photodegradation and a short half-life. Several newer 1,4-DHPs, including m-nifedipine and its analogs...
9.
Teng Z, Zhou S, Yang R, Liu X, Liu R, Yang X, et al.
Biol Pharm Bull
. 2007 Sep;
30(9):1628-33.
PMID: 17827711
Emodin has numerous biochemical and pharmacological activities, though information about its intestinal absorption and first-pass metabolism is scarce. The purpose of this study was to evaluate intestinal absorption and metabolism...
10.
Teng Z, Zhou S, Ran Y, Liu X, Yang R, Yang X, et al.
Biosci Biotechnol Biochem
. 2007 Jul;
71(7):1636-43.
PMID: 17617731
The intestinal absorption characteristics of anthraquinones emodin and chrysophanol were observed by measuring the intracellular accumulation across Caco-2 cells by the reverse-phase high performance liquid chromatography. The intracellular accumulation of...